STOCK TITAN

Inventiva SA ACT Porteur (IVEVF) Stock Price, News & Analysis

IVEVF OTC
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
4 12 sessions, October 15, 2025 to October 13, 2026
Largest daily move
-10.3% close of September 24, 2026

Company Description

Inventiva SA ACT Porteur (OTC: IVEVF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $751.2M.

IVEVF declined 1.2% in the week to October 13, 2026. The last closing price was $3.18.

For FY2025, Inventiva SA ACT Porteur reported revenue of $5.3M with net income of -$415.6M and diluted earnings per share of -$2.23.

This page collects what Stock Titan holds for IVEVF, including price data, SEC filings, financial highlights, and short interest trends.

Stock Performance

$3.18
No recent trading
Last close: October 13, 2026
-1.2%
1 week to October 13, 2026
$751.2M

Inventiva SA ACT Porteur (IVEVF) closed at $3.18 on October 13, 2026. In the week to October 13, 2026, the price lost 1.2%.

See what a $1,000 investment in IVEVF would be worth today

Average down calculator for IVEVF

IVEVF Metrics & Rankings

Market Cap
$751.2M
View ranking

Price returns through October 13, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

No recent news available for IVEVF.

Financial Highlights

Inventiva SA ACT Porteur generated $5.3M in revenue in FY2025, operating income reached -$165.5M, and net income was -$415.6M. Diluted earnings per share stood at -$2.23. The company generated -$123.1M in operating cash flow. The current ratio was 3.16, measuring current assets divided by current liabilities.

$5.3M
Revenue (FY2025)
-$415.6M
Net Income (FY2025)
-$123.1M
Operating Cash Flow

Upcoming Events

No upcoming events scheduled for IVEVF.

Short Interest History

Last 12 Months

Short interest in Inventiva SA ACT Porteur (IVEVF) currently stands at 97.7 thousand shares, down 51.4% from the previous reporting period, representing 0.1% of the float. Since November 2025, short interest has decreased by 47.8%.

Days to Cover History

Last 12 Months

Days to cover for Inventiva SA ACT Porteur (IVEVF) currently stands at 1000.0 days, up 587% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 4.6 to 1000.0 days.

IVEVF Company Profile & Sector Positioning

Inventiva SA ACT Porteur (IVEVF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.

Investors comparing IVEVF often look at related companies in the same sector, including Nxera Pharma Co Ltd (SOLTF), Oxford Biomedica plc New (OXBDF), Pharming Group NV (PHGUF), DBV Technologies SA (DBVTF), and Pharma Mar SA New (PHMMF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate IVEVF's relative position within its industry.

Frequently Asked Questions

Inventiva SA ACT Porteur (IVEVF) has no recent trading. Its last close was $3.18 on October 13, 2026.

The market cap of Inventiva SA ACT Porteur (IVEVF) is approximately $751.2M. Learn more about what market capitalization means .

The FY2025 revenue of Inventiva SA ACT Porteur (IVEVF) is $5.3M, from its most recent completed fiscal year.

The FY2025 net income of Inventiva SA ACT Porteur (IVEVF) is -$415.6M, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of Inventiva SA ACT Porteur (IVEVF) is -$2.23 for FY2025, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of Inventiva SA ACT Porteur (IVEVF) is -$123.1M for FY2025, its most recent completed fiscal year. Learn about cash flow.

The current ratio of Inventiva SA ACT Porteur (IVEVF), current assets divided by current liabilities, was 3.16 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

The operating income of Inventiva SA ACT Porteur (IVEVF) is -$165.5M for FY2025, its most recent completed fiscal year. Learn about operating income.